Transient acantholytic dermatosis after treatment with 2-chlorodeoxyadenosine.
Cohen
P R
PR
Kurzrock
R
R
D000051:Acantholysis / Q000139:chemically induced*; D000255:Adenosine Triphosphate / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017338:Cladribine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003875:Drug Eruptions / Q000209:etiology*; D004791:Enzyme Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007943:Leukemia, Hairy Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies
D004791:Enzyme Inhibitors; C097601:cladribine triphosphate; D017338:Cladribine; D000255:Adenosine Triphosphate